Ferozsons Laboratories Limited (PSX:FEROZ)

Market Cap	17.48B
Revenue (ttm)	18.86B
Net Income (ttm)	776.54M
Shares Out	43.47M
EPS (ttm)	17.86
PE Ratio	22.52
Forward PE	n/a
Dividend	4.00 (0.99%)
Ex-Dividend Date	Oct 16, 2025

Volume	49,051
Average Volume	86,057
Open	402.03
Previous Close	401.85
Day's Range	400.20 - 408.00
52-Week Range	242.33 - 464.00
Beta	0.33
RSI	39.93
Earnings Date	Sep 1, 2025

About Ferozsons Laboratories

Ferozsons Laboratories Limited, together with its subsidiaries, engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan, Afghanistan, Sri Lanka, the Philippines, Kenya, Myanmar, Kyrgyzstan, Mongolia, Cambodia, and internationally. The company offers products in various therapeutic areas of anti-fungal, anti-viral, antibiotics, cardiometabolic, cough, dermatology, diabetes, gastrointestinal and liver, oncology, orthopedic, and urology and nephrology areas. It also provides medical devices in t...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1954
• Employees: 1,896
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: FEROZ

Financial Performance

In 2025, Ferozsons Laboratories's revenue was 18.86 billion, an increase of 18.94% compared to the previous year's 15.85 billion. Earnings were 776.54 million, an increase of 13.67%.